Drugs / V950
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00464334 | Mar 2007 → Jan 2012 | Alzheimer disease | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V950 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00464334 ↗ |
| Modality | Vaccine | “an investigational vaccine, V950” NCT00464334 ↗ |